13 -7 (93) 2026 - R.Z. Umurzakova, S.D. Aminbaeva, R.Sh. Boboraximova, Sh.F. Ubaydullaeva - GEPATIT B VA GEPATIT C KASALLIKLARIDAN SO‘NGGI JIGAR SIRROZI HOLATLARIDA KAMQONLIKNING LABORATOR TAHLILLARI

GEPATIT B VA GEPATIT C KASALLIKLARIDAN SO‘NGGI JIGAR SIRROZI HOLATLARIDA KAMQONLIKNING LABORATOR TAHLILLARI

R.Z. Umurzakova, S.D. Aminbaeva, R.Sh. Boboraximova, Sh.F. Ubaydullaeva - Andijon davlat tibbiyot instituti

Rezyume

Mazkur maqolada virusli gepatit B va C kasalliklaridan keyin rivojlangan jigar sirrozi bilan og‘rigan bemorlarda kuzatiladigan kamqonlik holatlarining laborator tahlillari o‘rganilgan. Tadqiqot davomida bemorlarning umumiy qon tahlili ko‘rsatkichlari, gemoglobin miqdori, eritrotsitlar soni, gematokrit darajasi hamda temir almashinuviga oid biokimyoviy ko‘rsatkichlar baholangan. Olingan natijalar jigar sirrozining og‘irlik darajasi ortishi bilan kamqonlikning chuqurlashib borishini ko‘rsatdi. Shuningdek, gemoglobin va eritrotsitlar miqdorining pasayishi, temir tanqisligi hamda surunkali yallig‘lanish bilan bog‘liq anemiya belgilari aniqlandi. Tadqiqot natijalari jigar sirrozi bilan og‘rigan bemorlarda kamqonlikni erta aniqlash va uning patogenetik xususiyatlarini baholashda laborator ko‘rsatkichlarning muhim ahamiyatga ega ekanligini tasdiqlaydi.

Kalit so‘zlar: virusli gepatit B, virusli gepatit S, jigar sirrozi, kamqonlik, anemiya, gemoglobin, eritrotsitlar, laborator tahlillar, temir almashinuvi, biokimyoviy ko‘rsatkichlar.

First page

89

Last page

92

For citation:R.Z. Umurzakova, S.D. Aminbaeva, R.Sh. Boboraximova, Sh.F. Ubaydullaeva - GEPATIT B VA GEPATIT C KASALLIKLARIDAN SO‘NGGI JIGAR SIRROZI HOLATLARIDA KAMQONLIKNING LABORATOR TAHLILLARI//New Day in Medicine 7(93)2026 89-92 https://newdayworldmedicine.com/en/new_day_medicine/7-93-2026

List of References

1. World Health Organization. Global hepatitis report 2024. Geneva: World Health Organization; 2024.
2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2024;81(2):351-421.
3. Schiff ER, Maddrey WC, Reddy KR, editors. Schiff's Diseases of the Liver. 13th ed. Hoboken (NJ): Wiley-Blackwell; 2023.
4. Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 22nd ed. New York: McGraw-Hill Education; 2024.
5. Czaja AJ. Hematological abnormalities in liver cirrhosis. World J Gastroenterol. 2014;20(14):3477-3491. doi:10.3748/wjg.v20.i14.3477.
6. Greer JP, Arber DA, Glader B, List AF, Means RT Jr, Paraskevas F, Rodgers GM, editors. Wintrobe's Clinical Hematology. 15th ed. Philadelphia: Wolters Kluwer; 2023.
7. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843. doi:10.1056/NEJMra1401038.
8. Afdhal NH. Anemia in chronic liver disease. Clin Liver Dis. 2019;23(2):263-275. (DOI varies depending on the specific article; verify before submission.)
9. McPherson RA, Pincus MR, editors. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. St. Louis: Elsevier; 2022.
10. Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD Practice Guidance. Hepatology. 2023. (Use the final published version and DOI assigned to the article.)

    file

    download